NCT07498283Recruiting
Peer-Mentor Support for Vulnerable Patients With Atrial Fibrillation
Explore and Improve Mental Well-being Among Vulnerable Patients With Atrial Fibrillation - A Randomized Controlled Trial of a Peer-Mentor Intervention
Source: ClinicalTrials.gov · Last updated 5 Jun 2026
Brief summary (registry, in English)
The goal of this randomized clinical trial is to evaluate whether a peer-mentor intervention can improve mental well-being among vulnerable patients with atrial fibrillation (AF). Patients with AF often experience anxiety, uncertainty, and reduced quality of life. These challenges are particularly pronounced among individuals with low socioeconomic position, who may face additional barriers to accessing supportive care. The main question the study aims to answer is: Does a 16-week peer-mentor intervention reduce anxiety symptoms among patients with AF compared with usual care? Researchers will compare peer-mentor support plus usual care with usual care alone. Participants will: Complete questionnaires about anxiety, depressive symptoms, quality of life, and self-efficacy at baseline and after 16 weeks. Be randomized either to receive peer-mentor support for 16 weeks or to receive usual care only. If allocated to the intervention group, be matched with a trained peer mentor with lived experience of atrial fibrillation who provides emotional support and practical guidance through approximately eight contacts over the 16-week period. The study will also include follow-up using national health registers and a mixed-methods process evaluation exploring participants' and mentors' experiences with the intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 290 (estimated)
- First submitted
- 17 Mar 2026
- Start date
- 26 May 2026
- Primary completion date
- 1 Nov 2027
- Lead sponsor
- University College Copenhagen
- Diseases
- Atrial fibrillation
- NCT number
- NCT07498283
What you commit to
- Study type: Interventional
- Planned participants: 290
- From 26 May 2026 to the primary completion date, 1 Nov 2027
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to provide informed consent
Who the study is looking for
- Adults (≥18 years) with a confirmed diagnosis of atrial fibrillation
- Low socioeconomic position, primarily defined as educational attainment of vocational education or below
- Able to understand and speak Danish
- Able to provide written informed consent
- Able to complete study questionnaires
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Herlev and Gentofte Hospital Coordinator of this site? Confirm its status | Herlev | Denmark | Recruiting |
| Nordsjealland Hospital Coordinator of this site? Confirm its status | Hillerød | Denmark | Not yet recruiting |
| Amager and Hvidovre Hospital Coordinator of this site? Confirm its status | Hvidovre | Denmark | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.